Study to Review the Practices of “White Bagging” and “Brown Bagging” (Resolution 112-1-16)

Resolution No: 112-1-16
Title: Study to Review the Practices of “White Bagging” and “Brown Bagging”
Membership Vote: PASS

WHEREAS, “white bagging” generally refers to a patient-specific medication that is distributed by a pharmacy to a hospital, clinic, physician’s office, or pharmacy for later preparation and administration to a patient where allowed by law and “brown bagging” generally refers to a patient-specific medication that is dispensed by a pharmacy to the patient and then brought by the patient to the hospital, clinic, or physician’s office for administration;

WHEREAS, the practices of “white bagging” and “brown bagging” are becoming more prevalent and often defined and mandated by third-party payers outside of the authority of the state boards of pharmacy; and

WHEREAS, the need exists for the boards of pharmacy to define such practices and ensure appropriate regulatory oversight in order to protect patients;

THEREFORE BE IT RESOLVED that NABP conduct a study, which may include, if appropriate, other key health care stakeholders to review and define the practices of “white bagging” and “brown bagging” and recommend regulatory language, if necessary, to the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy to assist boards of pharmacy in overseeing and addressing the accountability and safety of medications dispensed and administered via these methods.

(Resolution passed at the 112^th Annual Meeting in San Diego, CA.)